nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—ulcerative colitis	0.174	0.512	CbGaD
Fluoxetine—ABCB1—ulcerative colitis	0.166	0.488	CbGaD
Fluoxetine—CYP2B6—Nicotine—ulcerative colitis	0.031	0.0722	CbGbCtD
Fluoxetine—CYP2B6—Cholecalciferol—ulcerative colitis	0.0278	0.0648	CbGbCtD
Fluoxetine—CYP3A4—Budesonide—ulcerative colitis	0.0219	0.051	CbGbCtD
Fluoxetine—CYP2C19—Nicotine—ulcerative colitis	0.0197	0.0459	CbGbCtD
Fluoxetine—CYP3A5—Sulfasalazine—ulcerative colitis	0.019	0.0443	CbGbCtD
Fluoxetine—ALB—Prednisone—ulcerative colitis	0.0189	0.044	CbGbCtD
Fluoxetine—CYP1A2—Nicotine—ulcerative colitis	0.0182	0.0424	CbGbCtD
Fluoxetine—CYP2C19—Cholecalciferol—ulcerative colitis	0.0176	0.0412	CbGbCtD
Fluoxetine—CYP2C9—Nicotine—ulcerative colitis	0.0164	0.0382	CbGbCtD
Fluoxetine—ABCB1—Methylprednisolone—ulcerative colitis	0.0163	0.038	CbGbCtD
Fluoxetine—CYP3A5—Hydrocortisone—ulcerative colitis	0.0152	0.0355	CbGbCtD
Fluoxetine—CYP2D6—Nicotine—ulcerative colitis	0.015	0.0349	CbGbCtD
Fluoxetine—CYP2C9—Cholecalciferol—ulcerative colitis	0.0147	0.0342	CbGbCtD
Fluoxetine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0134	0.0313	CbGbCtD
Fluoxetine—CYP2C19—Prednisone—ulcerative colitis	0.0122	0.0285	CbGbCtD
Fluoxetine—CYP2B6—Dexamethasone—ulcerative colitis	0.012	0.028	CbGbCtD
Fluoxetine—ABCB1—Betamethasone—ulcerative colitis	0.0106	0.0247	CbGbCtD
Fluoxetine—ABCB1—Prednisolone—ulcerative colitis	0.0105	0.0244	CbGbCtD
Fluoxetine—ABCB1—Hydrocortisone—ulcerative colitis	0.00991	0.0231	CbGbCtD
Fluoxetine—ABCB1—Prednisone—ulcerative colitis	0.00987	0.023	CbGbCtD
Fluoxetine—CYP3A4—Methylprednisolone—ulcerative colitis	0.00976	0.0228	CbGbCtD
Fluoxetine—CYP3A4—Nicotine—ulcerative colitis	0.00951	0.0222	CbGbCtD
Fluoxetine—CYP3A5—Dexamethasone—ulcerative colitis	0.00947	0.0221	CbGbCtD
Fluoxetine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00853	0.0199	CbGbCtD
Fluoxetine—CYP2C19—Dexamethasone—ulcerative colitis	0.00764	0.0178	CbGbCtD
Fluoxetine—CYP3A4—Triamcinolone—ulcerative colitis	0.0074	0.0173	CbGbCtD
Fluoxetine—CYP2C9—Dexamethasone—ulcerative colitis	0.00635	0.0148	CbGbCtD
Fluoxetine—CYP3A4—Betamethasone—ulcerative colitis	0.00635	0.0148	CbGbCtD
Fluoxetine—CYP3A4—Prednisolone—ulcerative colitis	0.00626	0.0146	CbGbCtD
Fluoxetine—ABCB1—Dexamethasone—ulcerative colitis	0.00616	0.0144	CbGbCtD
Fluoxetine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00594	0.0138	CbGbCtD
Fluoxetine—CYP3A4—Prednisone—ulcerative colitis	0.00591	0.0138	CbGbCtD
Fluoxetine—ORM1—bile—ulcerative colitis	0.00581	0.246	CbGeAlD
Fluoxetine—CYP2D6—Dexamethasone—ulcerative colitis	0.00581	0.0135	CbGbCtD
Fluoxetine—HTR2A—enteric nervous system—ulcerative colitis	0.00499	0.211	CbGeAlD
Fluoxetine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00378	0.16	CbGeAlD
Fluoxetine—CYP3A4—Dexamethasone—ulcerative colitis	0.00369	0.00861	CbGbCtD
Fluoxetine—SIGMAR1—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000721	1	CbGdCrCtD
Fluoxetine—SIGMAR1—smooth muscle tissue—ulcerative colitis	0.000681	0.0288	CbGeAlD
Fluoxetine—SLC6A4—digestive system—ulcerative colitis	0.000541	0.0229	CbGeAlD
Fluoxetine—ORM1—liver—ulcerative colitis	0.000473	0.02	CbGeAlD
Fluoxetine—CYP2C19—digestive system—ulcerative colitis	0.000448	0.019	CbGeAlD
Fluoxetine—ALB—liver—ulcerative colitis	0.000415	0.0176	CbGeAlD
Fluoxetine—SIGMAR1—liver—ulcerative colitis	0.0004	0.0169	CbGeAlD
Fluoxetine—HTR2A—epithelium—ulcerative colitis	0.000376	0.0159	CbGeAlD
Fluoxetine—CYP1A2—digestive system—ulcerative colitis	0.000366	0.0155	CbGeAlD
Fluoxetine—HTR2A—smooth muscle tissue—ulcerative colitis	0.000363	0.0154	CbGeAlD
Fluoxetine—CYP2B6—lymphoid tissue—ulcerative colitis	0.000355	0.015	CbGeAlD
Fluoxetine—CYP3A5—digestive system—ulcerative colitis	0.000353	0.015	CbGeAlD
Fluoxetine—CYP2B6—digestive system—ulcerative colitis	0.000351	0.0149	CbGeAlD
Fluoxetine—CYP2C9—digestive system—ulcerative colitis	0.000348	0.0147	CbGeAlD
Fluoxetine—CYP2C19—liver—ulcerative colitis	0.000334	0.0141	CbGeAlD
Fluoxetine—HTR2A—digestive system—ulcerative colitis	0.000286	0.0121	CbGeAlD
Fluoxetine—CYP1A2—liver—ulcerative colitis	0.000273	0.0115	CbGeAlD
Fluoxetine—CYP3A4—digestive system—ulcerative colitis	0.000265	0.0112	CbGeAlD
Fluoxetine—CYP3A5—liver—ulcerative colitis	0.000263	0.0111	CbGeAlD
Fluoxetine—CYP2B6—liver—ulcerative colitis	0.000262	0.0111	CbGeAlD
Fluoxetine—CYP2D6—digestive system—ulcerative colitis	0.000261	0.011	CbGeAlD
Fluoxetine—CYP2C9—liver—ulcerative colitis	0.000259	0.011	CbGeAlD
Fluoxetine—ABCB1—epithelium—ulcerative colitis	0.000247	0.0104	CbGeAlD
Fluoxetine—HTR2A—liver—ulcerative colitis	0.000213	0.00903	CbGeAlD
Fluoxetine—CYP3A4—liver—ulcerative colitis	0.000198	0.00836	CbGeAlD
Fluoxetine—CYP2D6—liver—ulcerative colitis	0.000194	0.00823	CbGeAlD
Fluoxetine—ABCB1—lymphoid tissue—ulcerative colitis	0.00019	0.00804	CbGeAlD
Fluoxetine—ABCB1—digestive system—ulcerative colitis	0.000188	0.00794	CbGeAlD
Fluoxetine—ABCB1—liver—ulcerative colitis	0.00014	0.00592	CbGeAlD
Fluoxetine—Anaphylactic shock—Hydrocortisone—ulcerative colitis	5.4e-05	0.000267	CcSEcCtD
Fluoxetine—Convulsion—Triamcinolone—ulcerative colitis	5.4e-05	0.000267	CcSEcCtD
Fluoxetine—Tachycardia—Prednisolone—ulcerative colitis	5.4e-05	0.000267	CcSEcCtD
Fluoxetine—Convulsion—Methylprednisolone—ulcerative colitis	5.39e-05	0.000267	CcSEcCtD
Fluoxetine—Hypertension—Triamcinolone—ulcerative colitis	5.38e-05	0.000266	CcSEcCtD
Fluoxetine—Pruritus—Mesalazine—ulcerative colitis	5.37e-05	0.000266	CcSEcCtD
Fluoxetine—Hypertension—Methylprednisolone—ulcerative colitis	5.37e-05	0.000266	CcSEcCtD
Fluoxetine—Infection—Hydrocortisone—ulcerative colitis	5.37e-05	0.000266	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisolone—ulcerative colitis	5.35e-05	0.000265	CcSEcCtD
Fluoxetine—Shock—Hydrocortisone—ulcerative colitis	5.31e-05	0.000263	CcSEcCtD
Fluoxetine—Myalgia—Triamcinolone—ulcerative colitis	5.31e-05	0.000263	CcSEcCtD
Fluoxetine—Vomiting—Azathioprine—ulcerative colitis	5.3e-05	0.000263	CcSEcCtD
Fluoxetine—Myalgia—Methylprednisolone—ulcerative colitis	5.29e-05	0.000262	CcSEcCtD
Fluoxetine—Arthralgia—Methylprednisolone—ulcerative colitis	5.29e-05	0.000262	CcSEcCtD
Fluoxetine—Anxiety—Methylprednisolone—ulcerative colitis	5.28e-05	0.000261	CcSEcCtD
Fluoxetine—Tachycardia—Hydrocortisone—ulcerative colitis	5.27e-05	0.000261	CcSEcCtD
Fluoxetine—Rash—Azathioprine—ulcerative colitis	5.26e-05	0.00026	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.26e-05	0.00026	CcSEcCtD
Fluoxetine—Dermatitis—Azathioprine—ulcerative colitis	5.25e-05	0.00026	CcSEcCtD
Fluoxetine—Skin disorder—Hydrocortisone—ulcerative colitis	5.25e-05	0.00026	CcSEcCtD
Fluoxetine—Ill-defined disorder—Dexamethasone—ulcerative colitis	5.25e-05	0.00026	CcSEcCtD
Fluoxetine—Ill-defined disorder—Betamethasone—ulcerative colitis	5.25e-05	0.00026	CcSEcCtD
Fluoxetine—Discomfort—Triamcinolone—ulcerative colitis	5.24e-05	0.00026	CcSEcCtD
Fluoxetine—Discomfort—Methylprednisolone—ulcerative colitis	5.23e-05	0.000259	CcSEcCtD
Fluoxetine—Headache—Azathioprine—ulcerative colitis	5.22e-05	0.000259	CcSEcCtD
Fluoxetine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.22e-05	0.000259	CcSEcCtD
Fluoxetine—Diarrhoea—Mesalazine—ulcerative colitis	5.2e-05	0.000257	CcSEcCtD
Fluoxetine—Dry mouth—Triamcinolone—ulcerative colitis	5.19e-05	0.000257	CcSEcCtD
Fluoxetine—Angioedema—Dexamethasone—ulcerative colitis	5.17e-05	0.000256	CcSEcCtD
Fluoxetine—Angioedema—Betamethasone—ulcerative colitis	5.17e-05	0.000256	CcSEcCtD
Fluoxetine—Anorexia—Hydrocortisone—ulcerative colitis	5.15e-05	0.000255	CcSEcCtD
Fluoxetine—Confusional state—Methylprednisolone—ulcerative colitis	5.12e-05	0.000253	CcSEcCtD
Fluoxetine—Malaise—Betamethasone—ulcerative colitis	5.1e-05	0.000252	CcSEcCtD
Fluoxetine—Malaise—Dexamethasone—ulcerative colitis	5.1e-05	0.000252	CcSEcCtD
Fluoxetine—Anaphylactic shock—Triamcinolone—ulcerative colitis	5.09e-05	0.000252	CcSEcCtD
Fluoxetine—Vertigo—Dexamethasone—ulcerative colitis	5.08e-05	0.000252	CcSEcCtD
Fluoxetine—Vertigo—Betamethasone—ulcerative colitis	5.08e-05	0.000252	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	5.07e-05	0.000251	CcSEcCtD
Fluoxetine—Syncope—Dexamethasone—ulcerative colitis	5.07e-05	0.000251	CcSEcCtD
Fluoxetine—Syncope—Betamethasone—ulcerative colitis	5.07e-05	0.000251	CcSEcCtD
Fluoxetine—Arrhythmia—Prednisone—ulcerative colitis	5.05e-05	0.00025	CcSEcCtD
Fluoxetine—Infection—Triamcinolone—ulcerative colitis	5.05e-05	0.00025	CcSEcCtD
Fluoxetine—Hypotension—Hydrocortisone—ulcerative colitis	5.05e-05	0.00025	CcSEcCtD
Fluoxetine—Infection—Methylprednisolone—ulcerative colitis	5.04e-05	0.00025	CcSEcCtD
Fluoxetine—Dizziness—Mesalazine—ulcerative colitis	5.02e-05	0.000249	CcSEcCtD
Fluoxetine—Shock—Triamcinolone—ulcerative colitis	5e-05	0.000248	CcSEcCtD
Fluoxetine—Insomnia—Prednisolone—ulcerative colitis	5e-05	0.000248	CcSEcCtD
Fluoxetine—Alopecia—Prednisone—ulcerative colitis	5e-05	0.000247	CcSEcCtD
Fluoxetine—Shock—Methylprednisolone—ulcerative colitis	4.99e-05	0.000247	CcSEcCtD
Fluoxetine—Loss of consciousness—Betamethasone—ulcerative colitis	4.97e-05	0.000246	CcSEcCtD
Fluoxetine—Loss of consciousness—Dexamethasone—ulcerative colitis	4.97e-05	0.000246	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisolone—ulcerative colitis	4.97e-05	0.000246	CcSEcCtD
Fluoxetine—Tachycardia—Triamcinolone—ulcerative colitis	4.96e-05	0.000246	CcSEcCtD
Fluoxetine—Mental disorder—Prednisone—ulcerative colitis	4.96e-05	0.000245	CcSEcCtD
Fluoxetine—Nausea—Azathioprine—ulcerative colitis	4.95e-05	0.000245	CcSEcCtD
Fluoxetine—Tachycardia—Methylprednisolone—ulcerative colitis	4.95e-05	0.000245	CcSEcCtD
Fluoxetine—Skin disorder—Methylprednisolone—ulcerative colitis	4.93e-05	0.000244	CcSEcCtD
Fluoxetine—Malnutrition—Prednisone—ulcerative colitis	4.92e-05	0.000244	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.92e-05	0.000244	CcSEcCtD
Fluoxetine—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.92e-05	0.000243	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.91e-05	0.000243	CcSEcCtD
Fluoxetine—Convulsion—Dexamethasone—ulcerative colitis	4.9e-05	0.000243	CcSEcCtD
Fluoxetine—Convulsion—Betamethasone—ulcerative colitis	4.9e-05	0.000243	CcSEcCtD
Fluoxetine—Insomnia—Hydrocortisone—ulcerative colitis	4.89e-05	0.000242	CcSEcCtD
Fluoxetine—Hypertension—Betamethasone—ulcerative colitis	4.88e-05	0.000242	CcSEcCtD
Fluoxetine—Hypertension—Dexamethasone—ulcerative colitis	4.88e-05	0.000242	CcSEcCtD
Fluoxetine—Paraesthesia—Hydrocortisone—ulcerative colitis	4.85e-05	0.00024	CcSEcCtD
Fluoxetine—Vomiting—Mesalazine—ulcerative colitis	4.83e-05	0.000239	CcSEcCtD
Fluoxetine—Myalgia—Betamethasone—ulcerative colitis	4.81e-05	0.000238	CcSEcCtD
Fluoxetine—Myalgia—Dexamethasone—ulcerative colitis	4.81e-05	0.000238	CcSEcCtD
Fluoxetine—Anxiety—Betamethasone—ulcerative colitis	4.8e-05	0.000238	CcSEcCtD
Fluoxetine—Anxiety—Dexamethasone—ulcerative colitis	4.8e-05	0.000238	CcSEcCtD
Fluoxetine—Rash—Mesalazine—ulcerative colitis	4.79e-05	0.000237	CcSEcCtD
Fluoxetine—Dermatitis—Mesalazine—ulcerative colitis	4.78e-05	0.000237	CcSEcCtD
Fluoxetine—Headache—Mesalazine—ulcerative colitis	4.76e-05	0.000236	CcSEcCtD
Fluoxetine—Discomfort—Betamethasone—ulcerative colitis	4.76e-05	0.000235	CcSEcCtD
Fluoxetine—Discomfort—Dexamethasone—ulcerative colitis	4.76e-05	0.000235	CcSEcCtD
Fluoxetine—Dyspepsia—Hydrocortisone—ulcerative colitis	4.75e-05	0.000235	CcSEcCtD
Fluoxetine—Hypotension—Methylprednisolone—ulcerative colitis	4.74e-05	0.000235	CcSEcCtD
Fluoxetine—Pain—Prednisolone—ulcerative colitis	4.73e-05	0.000234	CcSEcCtD
Fluoxetine—Decreased appetite—Hydrocortisone—ulcerative colitis	4.7e-05	0.000232	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.66e-05	0.000231	CcSEcCtD
Fluoxetine—Fatigue—Hydrocortisone—ulcerative colitis	4.66e-05	0.000231	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.63e-05	0.000229	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.62e-05	0.000229	CcSEcCtD
Fluoxetine—Pain—Hydrocortisone—ulcerative colitis	4.62e-05	0.000229	CcSEcCtD
Fluoxetine—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.61e-05	0.000228	CcSEcCtD
Fluoxetine—Anaphylactic shock—Betamethasone—ulcerative colitis	4.61e-05	0.000228	CcSEcCtD
Fluoxetine—Insomnia—Triamcinolone—ulcerative colitis	4.6e-05	0.000228	CcSEcCtD
Fluoxetine—Insomnia—Methylprednisolone—ulcerative colitis	4.59e-05	0.000227	CcSEcCtD
Fluoxetine—Infection—Betamethasone—ulcerative colitis	4.58e-05	0.000227	CcSEcCtD
Fluoxetine—Infection—Dexamethasone—ulcerative colitis	4.58e-05	0.000227	CcSEcCtD
Fluoxetine—Ill-defined disorder—Prednisone—ulcerative colitis	4.57e-05	0.000226	CcSEcCtD
Fluoxetine—Paraesthesia—Triamcinolone—ulcerative colitis	4.57e-05	0.000226	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisolone—ulcerative colitis	4.56e-05	0.000226	CcSEcCtD
Fluoxetine—Paraesthesia—Methylprednisolone—ulcerative colitis	4.56e-05	0.000226	CcSEcCtD
Fluoxetine—Anaemia—Prednisone—ulcerative colitis	4.55e-05	0.000225	CcSEcCtD
Fluoxetine—Shock—Betamethasone—ulcerative colitis	4.54e-05	0.000225	CcSEcCtD
Fluoxetine—Shock—Dexamethasone—ulcerative colitis	4.54e-05	0.000225	CcSEcCtD
Fluoxetine—Dyspnoea—Triamcinolone—ulcerative colitis	4.53e-05	0.000224	CcSEcCtD
Fluoxetine—Agitation—Prednisone—ulcerative colitis	4.53e-05	0.000224	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.52e-05	0.000224	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betamethasone—ulcerative colitis	4.52e-05	0.000224	CcSEcCtD
Fluoxetine—Nausea—Mesalazine—ulcerative colitis	4.51e-05	0.000223	CcSEcCtD
Fluoxetine—Tachycardia—Dexamethasone—ulcerative colitis	4.5e-05	0.000223	CcSEcCtD
Fluoxetine—Tachycardia—Betamethasone—ulcerative colitis	4.5e-05	0.000223	CcSEcCtD
Fluoxetine—Angioedema—Prednisone—ulcerative colitis	4.5e-05	0.000223	CcSEcCtD
Fluoxetine—Dyspepsia—Triamcinolone—ulcerative colitis	4.48e-05	0.000222	CcSEcCtD
Fluoxetine—Dyspepsia—Methylprednisolone—ulcerative colitis	4.47e-05	0.000221	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betamethasone—ulcerative colitis	4.46e-05	0.000221	CcSEcCtD
Fluoxetine—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.46e-05	0.000221	CcSEcCtD
Fluoxetine—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.45e-05	0.00022	CcSEcCtD
Fluoxetine—Malaise—Prednisone—ulcerative colitis	4.44e-05	0.00022	CcSEcCtD
Fluoxetine—Vertigo—Prednisone—ulcerative colitis	4.42e-05	0.000219	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.42e-05	0.000219	CcSEcCtD
Fluoxetine—Syncope—Prednisone—ulcerative colitis	4.42e-05	0.000219	CcSEcCtD
Fluoxetine—Anorexia—Dexamethasone—ulcerative colitis	4.4e-05	0.000218	CcSEcCtD
Fluoxetine—Anorexia—Betamethasone—ulcerative colitis	4.4e-05	0.000218	CcSEcCtD
Fluoxetine—Urticaria—Prednisolone—ulcerative colitis	4.39e-05	0.000218	CcSEcCtD
Fluoxetine—Fatigue—Triamcinolone—ulcerative colitis	4.38e-05	0.000217	CcSEcCtD
Fluoxetine—Fatigue—Methylprednisolone—ulcerative colitis	4.37e-05	0.000217	CcSEcCtD
Fluoxetine—Pain—Triamcinolone—ulcerative colitis	4.35e-05	0.000215	CcSEcCtD
Fluoxetine—Loss of consciousness—Prednisone—ulcerative colitis	4.33e-05	0.000214	CcSEcCtD
Fluoxetine—Hypotension—Dexamethasone—ulcerative colitis	4.31e-05	0.000213	CcSEcCtD
Fluoxetine—Hypotension—Betamethasone—ulcerative colitis	4.31e-05	0.000213	CcSEcCtD
Fluoxetine—Urticaria—Hydrocortisone—ulcerative colitis	4.29e-05	0.000212	CcSEcCtD
Fluoxetine—Body temperature increased—Hydrocortisone—ulcerative colitis	4.27e-05	0.000211	CcSEcCtD
Fluoxetine—Abdominal pain—Hydrocortisone—ulcerative colitis	4.27e-05	0.000211	CcSEcCtD
Fluoxetine—Convulsion—Prednisone—ulcerative colitis	4.27e-05	0.000211	CcSEcCtD
Fluoxetine—Hypertension—Prednisone—ulcerative colitis	4.25e-05	0.00021	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.2e-05	0.000208	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.2e-05	0.000208	CcSEcCtD
Fluoxetine—Arthralgia—Prednisone—ulcerative colitis	4.19e-05	0.000208	CcSEcCtD
Fluoxetine—Myalgia—Prednisone—ulcerative colitis	4.19e-05	0.000208	CcSEcCtD
Fluoxetine—Feeling abnormal—Triamcinolone—ulcerative colitis	4.19e-05	0.000208	CcSEcCtD
Fluoxetine—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.18e-05	0.000207	CcSEcCtD
Fluoxetine—Anxiety—Prednisone—ulcerative colitis	4.18e-05	0.000207	CcSEcCtD
Fluoxetine—Insomnia—Dexamethasone—ulcerative colitis	4.17e-05	0.000207	CcSEcCtD
Fluoxetine—Insomnia—Betamethasone—ulcerative colitis	4.17e-05	0.000207	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.16e-05	0.000206	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.15e-05	0.000205	CcSEcCtD
Fluoxetine—Paraesthesia—Dexamethasone—ulcerative colitis	4.14e-05	0.000205	CcSEcCtD
Fluoxetine—Paraesthesia—Betamethasone—ulcerative colitis	4.14e-05	0.000205	CcSEcCtD
Fluoxetine—Discomfort—Prednisone—ulcerative colitis	4.14e-05	0.000205	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisolone—ulcerative colitis	4.07e-05	0.000202	CcSEcCtD
Fluoxetine—Dyspepsia—Betamethasone—ulcerative colitis	4.06e-05	0.000201	CcSEcCtD
Fluoxetine—Dyspepsia—Dexamethasone—ulcerative colitis	4.06e-05	0.000201	CcSEcCtD
Fluoxetine—Urticaria—Triamcinolone—ulcerative colitis	4.04e-05	0.0002	CcSEcCtD
Fluoxetine—Urticaria—Methylprednisolone—ulcerative colitis	4.03e-05	0.0002	CcSEcCtD
Fluoxetine—Body temperature increased—Triamcinolone—ulcerative colitis	4.02e-05	0.000199	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisone—ulcerative colitis	4.02e-05	0.000199	CcSEcCtD
Fluoxetine—Abdominal pain—Methylprednisolone—ulcerative colitis	4.01e-05	0.000199	CcSEcCtD
Fluoxetine—Decreased appetite—Betamethasone—ulcerative colitis	4.01e-05	0.000199	CcSEcCtD
Fluoxetine—Decreased appetite—Dexamethasone—ulcerative colitis	4.01e-05	0.000199	CcSEcCtD
Fluoxetine—Infection—Prednisone—ulcerative colitis	3.99e-05	0.000198	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.98e-05	0.000197	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.98e-05	0.000197	CcSEcCtD
Fluoxetine—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.98e-05	0.000197	CcSEcCtD
Fluoxetine—Fatigue—Betamethasone—ulcerative colitis	3.98e-05	0.000197	CcSEcCtD
Fluoxetine—Fatigue—Dexamethasone—ulcerative colitis	3.98e-05	0.000197	CcSEcCtD
Fluoxetine—Shock—Prednisone—ulcerative colitis	3.95e-05	0.000196	CcSEcCtD
Fluoxetine—Pain—Betamethasone—ulcerative colitis	3.95e-05	0.000195	CcSEcCtD
Fluoxetine—Pain—Dexamethasone—ulcerative colitis	3.95e-05	0.000195	CcSEcCtD
Fluoxetine—Tachycardia—Prednisone—ulcerative colitis	3.92e-05	0.000194	CcSEcCtD
Fluoxetine—Skin disorder—Prednisone—ulcerative colitis	3.9e-05	0.000193	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisone—ulcerative colitis	3.88e-05	0.000192	CcSEcCtD
Fluoxetine—Asthenia—Hydrocortisone—ulcerative colitis	3.88e-05	0.000192	CcSEcCtD
Fluoxetine—Anorexia—Prednisone—ulcerative colitis	3.83e-05	0.00019	CcSEcCtD
Fluoxetine—Pruritus—Hydrocortisone—ulcerative colitis	3.82e-05	0.000189	CcSEcCtD
Fluoxetine—Feeling abnormal—Betamethasone—ulcerative colitis	3.8e-05	0.000188	CcSEcCtD
Fluoxetine—Feeling abnormal—Dexamethasone—ulcerative colitis	3.8e-05	0.000188	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.77e-05	0.000187	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.77e-05	0.000187	CcSEcCtD
Fluoxetine—Hypersensitivity—Triamcinolone—ulcerative colitis	3.75e-05	0.000186	CcSEcCtD
Fluoxetine—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.74e-05	0.000185	CcSEcCtD
Fluoxetine—Diarrhoea—Hydrocortisone—ulcerative colitis	3.7e-05	0.000183	CcSEcCtD
Fluoxetine—Urticaria—Betamethasone—ulcerative colitis	3.67e-05	0.000182	CcSEcCtD
Fluoxetine—Urticaria—Dexamethasone—ulcerative colitis	3.67e-05	0.000182	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.66e-05	0.000181	CcSEcCtD
Fluoxetine—Dizziness—Prednisolone—ulcerative colitis	3.66e-05	0.000181	CcSEcCtD
Fluoxetine—Asthenia—Triamcinolone—ulcerative colitis	3.65e-05	0.000181	CcSEcCtD
Fluoxetine—Body temperature increased—Dexamethasone—ulcerative colitis	3.65e-05	0.000181	CcSEcCtD
Fluoxetine—Abdominal pain—Dexamethasone—ulcerative colitis	3.65e-05	0.000181	CcSEcCtD
Fluoxetine—Body temperature increased—Betamethasone—ulcerative colitis	3.65e-05	0.000181	CcSEcCtD
Fluoxetine—Abdominal pain—Betamethasone—ulcerative colitis	3.65e-05	0.000181	CcSEcCtD
Fluoxetine—Asthenia—Methylprednisolone—ulcerative colitis	3.64e-05	0.00018	CcSEcCtD
Fluoxetine—Insomnia—Prednisone—ulcerative colitis	3.63e-05	0.00018	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisone—ulcerative colitis	3.61e-05	0.000179	CcSEcCtD
Fluoxetine—Pruritus—Triamcinolone—ulcerative colitis	3.6e-05	0.000178	CcSEcCtD
Fluoxetine—Pruritus—Methylprednisolone—ulcerative colitis	3.59e-05	0.000178	CcSEcCtD
Fluoxetine—Dizziness—Hydrocortisone—ulcerative colitis	3.57e-05	0.000177	CcSEcCtD
Fluoxetine—Dyspepsia—Prednisone—ulcerative colitis	3.54e-05	0.000175	CcSEcCtD
Fluoxetine—Decreased appetite—Prednisone—ulcerative colitis	3.49e-05	0.000173	CcSEcCtD
Fluoxetine—Rash—Prednisolone—ulcerative colitis	3.49e-05	0.000173	CcSEcCtD
Fluoxetine—Dermatitis—Prednisolone—ulcerative colitis	3.48e-05	0.000172	CcSEcCtD
Fluoxetine—Diarrhoea—Methylprednisolone—ulcerative colitis	3.47e-05	0.000172	CcSEcCtD
Fluoxetine—Fatigue—Prednisone—ulcerative colitis	3.46e-05	0.000172	CcSEcCtD
Fluoxetine—Headache—Prednisolone—ulcerative colitis	3.46e-05	0.000172	CcSEcCtD
Fluoxetine—Constipation—Prednisone—ulcerative colitis	3.44e-05	0.00017	CcSEcCtD
Fluoxetine—Vomiting—Hydrocortisone—ulcerative colitis	3.43e-05	0.00017	CcSEcCtD
Fluoxetine—Rash—Hydrocortisone—ulcerative colitis	3.41e-05	0.000169	CcSEcCtD
Fluoxetine—Dermatitis—Hydrocortisone—ulcerative colitis	3.4e-05	0.000168	CcSEcCtD
Fluoxetine—Headache—Hydrocortisone—ulcerative colitis	3.38e-05	0.000168	CcSEcCtD
Fluoxetine—Dizziness—Triamcinolone—ulcerative colitis	3.36e-05	0.000167	CcSEcCtD
Fluoxetine—Dizziness—Methylprednisolone—ulcerative colitis	3.36e-05	0.000166	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisone—ulcerative colitis	3.31e-05	0.000164	CcSEcCtD
Fluoxetine—Asthenia—Dexamethasone—ulcerative colitis	3.31e-05	0.000164	CcSEcCtD
Fluoxetine—Asthenia—Betamethasone—ulcerative colitis	3.31e-05	0.000164	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Prednisone—ulcerative colitis	3.29e-05	0.000163	CcSEcCtD
Fluoxetine—Nausea—Prednisolone—ulcerative colitis	3.28e-05	0.000163	CcSEcCtD
Fluoxetine—Pruritus—Dexamethasone—ulcerative colitis	3.26e-05	0.000162	CcSEcCtD
Fluoxetine—Pruritus—Betamethasone—ulcerative colitis	3.26e-05	0.000162	CcSEcCtD
Fluoxetine—Vomiting—Triamcinolone—ulcerative colitis	3.23e-05	0.00016	CcSEcCtD
Fluoxetine—Vomiting—Methylprednisolone—ulcerative colitis	3.23e-05	0.00016	CcSEcCtD
Fluoxetine—Nausea—Hydrocortisone—ulcerative colitis	3.21e-05	0.000159	CcSEcCtD
Fluoxetine—Rash—Triamcinolone—ulcerative colitis	3.21e-05	0.000159	CcSEcCtD
Fluoxetine—Dermatitis—Triamcinolone—ulcerative colitis	3.2e-05	0.000159	CcSEcCtD
Fluoxetine—Rash—Methylprednisolone—ulcerative colitis	3.2e-05	0.000158	CcSEcCtD
Fluoxetine—Dermatitis—Methylprednisolone—ulcerative colitis	3.2e-05	0.000158	CcSEcCtD
Fluoxetine—Urticaria—Prednisone—ulcerative colitis	3.19e-05	0.000158	CcSEcCtD
Fluoxetine—Headache—Triamcinolone—ulcerative colitis	3.19e-05	0.000158	CcSEcCtD
Fluoxetine—Headache—Methylprednisolone—ulcerative colitis	3.18e-05	0.000157	CcSEcCtD
Fluoxetine—Abdominal pain—Prednisone—ulcerative colitis	3.18e-05	0.000157	CcSEcCtD
Fluoxetine—Body temperature increased—Prednisone—ulcerative colitis	3.18e-05	0.000157	CcSEcCtD
Fluoxetine—Diarrhoea—Dexamethasone—ulcerative colitis	3.16e-05	0.000156	CcSEcCtD
Fluoxetine—Diarrhoea—Betamethasone—ulcerative colitis	3.16e-05	0.000156	CcSEcCtD
Fluoxetine—Dizziness—Betamethasone—ulcerative colitis	3.05e-05	0.000151	CcSEcCtD
Fluoxetine—Dizziness—Dexamethasone—ulcerative colitis	3.05e-05	0.000151	CcSEcCtD
Fluoxetine—Nausea—Triamcinolone—ulcerative colitis	3.02e-05	0.00015	CcSEcCtD
Fluoxetine—Nausea—Methylprednisolone—ulcerative colitis	3.01e-05	0.000149	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisone—ulcerative colitis	2.96e-05	0.000147	CcSEcCtD
Fluoxetine—Vomiting—Betamethasone—ulcerative colitis	2.93e-05	0.000145	CcSEcCtD
Fluoxetine—Vomiting—Dexamethasone—ulcerative colitis	2.93e-05	0.000145	CcSEcCtD
Fluoxetine—Rash—Dexamethasone—ulcerative colitis	2.91e-05	0.000144	CcSEcCtD
Fluoxetine—Rash—Betamethasone—ulcerative colitis	2.91e-05	0.000144	CcSEcCtD
Fluoxetine—Dermatitis—Dexamethasone—ulcerative colitis	2.91e-05	0.000144	CcSEcCtD
Fluoxetine—Dermatitis—Betamethasone—ulcerative colitis	2.91e-05	0.000144	CcSEcCtD
Fluoxetine—Headache—Betamethasone—ulcerative colitis	2.89e-05	0.000143	CcSEcCtD
Fluoxetine—Headache—Dexamethasone—ulcerative colitis	2.89e-05	0.000143	CcSEcCtD
Fluoxetine—Asthenia—Prednisone—ulcerative colitis	2.88e-05	0.000143	CcSEcCtD
Fluoxetine—Pruritus—Prednisone—ulcerative colitis	2.84e-05	0.000141	CcSEcCtD
Fluoxetine—Diarrhoea—Prednisone—ulcerative colitis	2.75e-05	0.000136	CcSEcCtD
Fluoxetine—Nausea—Betamethasone—ulcerative colitis	2.74e-05	0.000136	CcSEcCtD
Fluoxetine—Nausea—Dexamethasone—ulcerative colitis	2.74e-05	0.000136	CcSEcCtD
Fluoxetine—Dizziness—Prednisone—ulcerative colitis	2.66e-05	0.000132	CcSEcCtD
Fluoxetine—Vomiting—Prednisone—ulcerative colitis	2.56e-05	0.000127	CcSEcCtD
Fluoxetine—Rash—Prednisone—ulcerative colitis	2.53e-05	0.000125	CcSEcCtD
Fluoxetine—Dermatitis—Prednisone—ulcerative colitis	2.53e-05	0.000125	CcSEcCtD
Fluoxetine—Headache—Prednisone—ulcerative colitis	2.52e-05	0.000125	CcSEcCtD
Fluoxetine—Nausea—Prednisone—ulcerative colitis	2.39e-05	0.000118	CcSEcCtD
Fluoxetine—HTR2C—GPCR downstream signaling—CCL20—ulcerative colitis	8.01e-06	0.00138	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—ADRB2—ulcerative colitis	7.93e-06	0.00136	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	7.93e-06	0.00136	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCR1—ulcerative colitis	7.93e-06	0.00136	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—IL2—ulcerative colitis	7.9e-06	0.00136	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	7.74e-06	0.00133	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	7.62e-06	0.00131	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TNF—ulcerative colitis	7.58e-06	0.0013	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	7.58e-06	0.0013	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—GNA12—ulcerative colitis	7.54e-06	0.0013	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	7.52e-06	0.00129	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	7.44e-06	0.00128	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—GNA12—ulcerative colitis	7.43e-06	0.00128	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	7.35e-06	0.00127	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	7.31e-06	0.00126	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—ITGAL—ulcerative colitis	7.3e-06	0.00126	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCL20—ulcerative colitis	7.28e-06	0.00125	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCR1—ulcerative colitis	7.2e-06	0.00124	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCR2—ulcerative colitis	7.14e-06	0.00123	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	7.11e-06	0.00122	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	7.08e-06	0.00122	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	7.08e-06	0.00122	CbGpPWpGaD
Fluoxetine—ALB—Platelet degranulation—TGFB1—ulcerative colitis	6.96e-06	0.0012	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCL20—ulcerative colitis	6.96e-06	0.0012	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.93e-06	0.00119	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—ADRB2—ulcerative colitis	6.89e-06	0.00119	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—GNA12—ulcerative colitis	6.84e-06	0.00118	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	6.82e-06	0.00117	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCR6—ulcerative colitis	6.72e-06	0.00116	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TP53—ulcerative colitis	6.68e-06	0.00115	CbGpPWpGaD
Fluoxetine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	6.63e-06	0.00114	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CHP1—ulcerative colitis	6.63e-06	0.00114	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—GNA12—ulcerative colitis	6.54e-06	0.00113	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCR2—ulcerative colitis	6.49e-06	0.00112	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CHP1—ulcerative colitis	6.48e-06	0.00112	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.46e-06	0.00111	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.46e-06	0.00111	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—TP53—ulcerative colitis	6.35e-06	0.00109	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL20—ulcerative colitis	6.32e-06	0.00109	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCR2—ulcerative colitis	6.2e-06	0.00107	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	6.16e-06	0.00106	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—IL6—ulcerative colitis	6.12e-06	0.00105	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCR6—ulcerative colitis	6.1e-06	0.00105	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.05e-06	0.00104	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	6.02e-06	0.00104	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SEL1L—ulcerative colitis	5.95e-06	0.00102	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—GNA12—ulcerative colitis	5.94e-06	0.00102	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—PTGER4—ulcerative colitis	5.91e-06	0.00102	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCR6—ulcerative colitis	5.83e-06	0.001	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—IL6—ulcerative colitis	5.81e-06	0.001	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—TNF—ulcerative colitis	5.75e-06	0.00099	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—DLD—ulcerative colitis	5.72e-06	0.000985	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCR2—ulcerative colitis	5.63e-06	0.000969	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—DLD—ulcerative colitis	5.59e-06	0.000963	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CHP1—ulcerative colitis	5.58e-06	0.000961	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—GHRL—ulcerative colitis	5.41e-06	0.000932	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—PTGER4—ulcerative colitis	5.37e-06	0.000924	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	5.31e-06	0.000913	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.3e-06	0.000912	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCR6—ulcerative colitis	5.3e-06	0.000911	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.23e-06	0.0009	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—CALM3—ulcerative colitis	5.17e-06	0.00089	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SEL1L—ulcerative colitis	5.16e-06	0.000889	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—PTGER4—ulcerative colitis	5.13e-06	0.000884	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.03e-06	0.000866	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CHP1—ulcerative colitis	5.01e-06	0.000862	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—GHRL—ulcerative colitis	4.92e-06	0.000846	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCR1—ulcerative colitis	4.9e-06	0.000843	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CHP1—ulcerative colitis	4.89e-06	0.000842	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	4.86e-06	0.000837	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—DLD—ulcerative colitis	4.82e-06	0.000829	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CALM3—ulcerative colitis	4.76e-06	0.000819	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—GHRL—ulcerative colitis	4.7e-06	0.000809	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.7e-06	0.000808	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—PTGER4—ulcerative colitis	4.66e-06	0.000802	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.61e-06	0.000793	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CHP1—ulcerative colitis	4.57e-06	0.000786	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	4.54e-06	0.000781	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—ADRB2—ulcerative colitis	4.48e-06	0.000771	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.37e-06	0.000752	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.33e-06	0.000746	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—DLD—ulcerative colitis	4.33e-06	0.000744	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL20—ulcerative colitis	4.3e-06	0.00074	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	4.28e-06	0.000737	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.28e-06	0.000737	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—GHRL—ulcerative colitis	4.27e-06	0.000735	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCR1—ulcerative colitis	4.25e-06	0.000732	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—DLD—ulcerative colitis	4.22e-06	0.000727	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.21e-06	0.000724	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CALM3—ulcerative colitis	4.13e-06	0.000712	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADRB2—ulcerative colitis	4.07e-06	0.0007	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GNA12—ulcerative colitis	4.04e-06	0.000696	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—DLD—ulcerative colitis	3.98e-06	0.000685	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.96e-06	0.000681	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—DLD—ulcerative colitis	3.94e-06	0.000679	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CHP1—ulcerative colitis	3.9e-06	0.000672	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	3.89e-06	0.00067	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCR2—ulcerative colitis	3.83e-06	0.000659	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CXCL8—ulcerative colitis	3.83e-06	0.000659	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.82e-06	0.000657	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—ADCY5—ulcerative colitis	3.8e-06	0.000655	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	3.73e-06	0.000643	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.66e-06	0.00063	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.65e-06	0.000628	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCR6—ulcerative colitis	3.6e-06	0.00062	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	3.53e-06	0.000608	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	3.51e-06	0.000604	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.48e-06	0.000599	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADCY5—ulcerative colitis	3.45e-06	0.000594	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MAML2—ulcerative colitis	3.42e-06	0.000588	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—DLD—ulcerative colitis	3.37e-06	0.00058	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	3.33e-06	0.000573	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	3.33e-06	0.000572	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—MMP1—ulcerative colitis	3.32e-06	0.000571	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.31e-06	0.00057	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	3.3e-06	0.000568	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.25e-06	0.000559	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PTGER4—ulcerative colitis	3.17e-06	0.000546	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	3.13e-06	0.000538	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	3.09e-06	0.000531	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.04e-06	0.000523	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.01e-06	0.000519	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	3e-06	0.000516	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	2.97e-06	0.00051	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—GHRL—ulcerative colitis	2.9e-06	0.0005	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.85e-06	0.00049	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.84e-06	0.000489	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CALM3—ulcerative colitis	2.81e-06	0.000484	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RIPK2—ulcerative colitis	2.77e-06	0.000477	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS1—ulcerative colitis	2.77e-06	0.000476	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	2.75e-06	0.000474	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS1—ulcerative colitis	2.7e-06	0.000465	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—DLD—ulcerative colitis	2.6e-06	0.000448	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.55e-06	0.000439	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	2.52e-06	0.000434	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.5e-06	0.000431	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CALM3—ulcerative colitis	2.49e-06	0.000429	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	2.44e-06	0.00042	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CALM3—ulcerative colitis	2.44e-06	0.000419	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	2.41e-06	0.000414	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	2.4e-06	0.000414	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	2.37e-06	0.000408	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—JAK2—ulcerative colitis	2.34e-06	0.000403	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS1—ulcerative colitis	2.33e-06	0.000401	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.29e-06	0.000394	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	2.16e-06	0.000372	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	2.15e-06	0.000371	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CALM3—ulcerative colitis	2.1e-06	0.000361	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS1—ulcerative colitis	2.09e-06	0.00036	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	2.09e-06	0.000359	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.09e-06	0.000359	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	2.07e-06	0.000356	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	2.06e-06	0.000354	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.06e-06	0.000354	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS1—ulcerative colitis	2.04e-06	0.000351	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IL2—ulcerative colitis	2.04e-06	0.000351	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	2.04e-06	0.000351	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2e-06	0.000345	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	1.97e-06	0.000338	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCB1—ulcerative colitis	1.94e-06	0.000333	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.92e-06	0.000331	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.91e-06	0.000328	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.91e-06	0.000328	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.89e-06	0.000326	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.88e-06	0.000324	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.88e-06	0.000323	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	1.88e-06	0.000323	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.88e-06	0.000323	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	1.87e-06	0.000322	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CALM3—ulcerative colitis	1.84e-06	0.000316	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADCY5—ulcerative colitis	1.81e-06	0.000311	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.8e-06	0.00031	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	1.8e-06	0.000309	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.78e-06	0.000307	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	1.77e-06	0.000305	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.77e-06	0.000304	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.73e-06	0.000298	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CALM3—ulcerative colitis	1.72e-06	0.000295	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.71e-06	0.000294	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.64e-06	0.000282	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	1.63e-06	0.000281	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCB1—ulcerative colitis	1.63e-06	0.000281	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.63e-06	0.00028	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.6e-06	0.000276	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TGFB1—ulcerative colitis	1.59e-06	0.000274	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADCY5—ulcerative colitis	1.52e-06	0.000262	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.47e-06	0.000252	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCB1—ulcerative colitis	1.46e-06	0.000252	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.4e-06	0.000241	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADCY5—ulcerative colitis	1.37e-06	0.000235	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PPARG—ulcerative colitis	1.35e-06	0.000232	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.35e-06	0.000232	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.34e-06	0.00023	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.33e-06	0.000229	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.32e-06	0.000227	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TP53—ulcerative colitis	1.31e-06	0.000226	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	1.27e-06	0.000219	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.26e-06	0.000216	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.26e-06	0.000216	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.25e-06	0.000214	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	1.23e-06	0.000212	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—ulcerative colitis	1.21e-06	0.000209	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—ulcerative colitis	1.18e-06	0.000204	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	1.16e-06	0.0002	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.14e-06	0.000196	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARG—ulcerative colitis	1.13e-06	0.000195	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.13e-06	0.000195	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	1.11e-06	0.000191	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	1.1e-06	0.00019	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	1.1e-06	0.00019	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	1.07e-06	0.000184	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.06e-06	0.000183	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—ulcerative colitis	1.06e-06	0.000182	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	1.05e-06	0.000181	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	1.04e-06	0.000179	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—ulcerative colitis	1.04e-06	0.000178	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.02e-06	0.000175	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	1.01e-06	0.000174	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARG—ulcerative colitis	9.94e-07	0.000171	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	9.64e-07	0.000166	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	9.59e-07	0.000165	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARG—ulcerative colitis	9.37e-07	0.000161	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	9.34e-07	0.000161	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARG—ulcerative colitis	9.29e-07	0.00016	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—ulcerative colitis	9.16e-07	0.000158	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	9.12e-07	0.000157	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	9.02e-07	0.000155	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—ulcerative colitis	8.94e-07	0.000154	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—ulcerative colitis	8.93e-07	0.000154	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	8.8e-07	0.000152	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	8.65e-07	0.000149	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—ulcerative colitis	8.42e-07	0.000145	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—ulcerative colitis	8.35e-07	0.000144	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	8.21e-07	0.000141	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	8.11e-07	0.00014	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—ulcerative colitis	8.01e-07	0.000138	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARG—ulcerative colitis	7.94e-07	0.000137	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—ulcerative colitis	7.82e-07	0.000135	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	7.52e-07	0.000129	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	7.37e-07	0.000127	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—ulcerative colitis	7.31e-07	0.000126	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—ulcerative colitis	7.14e-07	0.000123	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	7.13e-07	0.000123	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	6.52e-07	0.000112	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	6.24e-07	0.000107	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	6.19e-07	0.000106	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARG—ulcerative colitis	6.13e-07	0.000105	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	5.66e-07	9.75e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—ulcerative colitis	5.51e-07	9.48e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.82e-07	8.29e-05	CbGpPWpGaD
